Previously we highlighted APP and Psen1 as good candidate modifiers in these regions since they have known links to Alzheimer's disease and Tau hyperphosphorylation [28], however, we did not detect significant differences in expression of APP or Psen1 between C57BL/6 and BALB/c samples. This evidence concerns the gene PSEN1 and Alzheimer disease.